Tag: pharmaceuticals
-
Immunotherapy Biotech Raises $102 Million in IPO
A biotechnology company developing treatments for solid tumors, harnessing the body’s immune system, for cancer patients most likely to respond is raising $102 million in its initial public stock offering.
-
Simpler Lab Cell Production Techniques Devised
A process is being developed that makes it easier to produce healthy and diseased cells in the lab from human specimens for regenerative medicine and research.
-
Allergy Immunotherapy Firm Raises $2M in Early Funds
A biotechnology company in Finland developing an allergy vaccine that harnesses the immune system is raising €1.85 million ($US 2 million) in its first venture funding round.
-
Biopharm, Hospital to Partner on Cell Energy Diseases
A biopharmaceutical company in Sweden and children’s hospital in the U.S. are collaborating on research into deficiencies in cells’ energy components responsible for a number of genetic disorders.
-
Safer Engineered-Cell Cancer Immunotherapy Designed
A biotechnology company designed a new type of engineered T-cell from the immune system that more precisely targets tumors and stays away from healthy cells.
-
FDA Begins Cancer Product Review Center
The U.S. Food and Drug Administration is reorganizing its review of treatments for cancer into a structure that cuts across its traditional bureaucratic lines.
-
Lilly Acquires Migraine Therapy Company in $960M Deal
Drug maker Eli Lilly and Company is acquiring CoLucid Pharmaceuticals, a developer of treatments for migraine pain and associated symptoms.
-
Pharma Firms Start Non-Communicable Disease Initiative
A group of 22 pharmaceutical companies is supporting worldwide projects to improve access to prevention and treatments for chronic disorders like cancer and heart disease, in lower-resource regions.
-
Experimental Drug Shown to Reduce Tourette’s Symptoms
Results from a clinical trial show an experimental drug is effective in reducing the severity of tics in children with Tourette’s syndrome, a neurological disorder.
-
Electronic Gene Editing Corrects Inherited Blood Disorder
A team at National Institutes of Health used an electronic-aided process to carry out a gene editing technique that in lab mice repaired a genetic defect causing a rare blood disease.